Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Flibanserin for Treating Hypoactive Sexual Desire DisorderFlibanserin for Treating Hypoactive Sexual Desire Disorder
- Other Titles
- Flibanserin for Treating Hypoactive Sexual Desire Disorder
- Issue Date
- 2016
- Publisher
- 대한폐경학회
- Keywords
- Flibanserin; Sexual behavior; Sexual dysfunctions; psychological; Sildenafil citrate
- Citation
- 대한폐경학회지, v.22, no.1, pp 9 - 13
- Pages
- 5
- Journal Title
- 대한폐경학회지
- Volume
- 22
- Number
- 1
- Start Page
- 9
- End Page
- 13
- ISSN
- 2288-6478
2288-6761
- Abstract
- There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.[1] On the other hand, flibanserin is thought to act on brain. Flibanserin has been approved by U. S. Food and Drug Administration (FDA) for treatment of hypoactive sexual desire disorder (HSDD) of premenopausal women in 2015, and is expected to be released in South Korea soon. Authors wrote this article to acknowledge flibanserin to sexologists for females or physicians for menopausal medicine, so that this agent can be safely used for females who have HSDD. (J Menopausal Med 2016;22:9-13)
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Obstetrics and Gynecology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Sang, Jae Hong
- College of Medicine (Department of Obstetrics and Gynecology)